RedHill Biopharma to Host Full-Year 2019 Financial Results Conference Call on March 4, 2020

NEXT STORY
MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors
PREV STORY
Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By Technology, By Application, By Region And Segment Forecasts, 2020 – 2027
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

– FCX-007 well-tolerated up to 52 weeks post-administration – – Continued positive trends noted ...

author_avatar
NASDAQ Market News

Todos Medical Announces Positive Data for Serology Point-of-Care Fingerprick Antibody Test Kits

author_avatar
NASDAQ Market News

Emergency Medical Equipment Market Value Anticipated To Reach US$ 30.4 Billion By 2027: Acumen Research and Consulting

author_avatar
NASDAQ Market News